Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a new revision version (v3.5.3), replacing the previous v3.5.2, indicating a small update to the page's metadata. This change updates the revision timestamp on the ClinicalTrials.gov record without altering the study information.SummaryDifference0.1%

- Check16 days agoChange DetectedStudy record timeline dates were updated, including added/revised dates for last update posting and estimated completion, along with removal of older date values.SummaryDifference0.3%

- Check23 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No other visible content changes are indicated.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded 'Hepatocellular carcinoma' as a disease term on the page. Updated the page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check81 days agoChange DetectedGastric cancer added as a condition for the study. Resources section now includes a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.